Nova Ltd. logo

Nova Ltd. (NVMI)

Market Closed
3 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
530. 04
+6.91
+1.32%
$
16.28B Market Cap
- P/E Ratio
- Div Yield
244,585 Volume
- Eps
$ 523.13
Previous Close
Add Transaction
Day Range
511.02 536.33
Year Range
206.42 565
Want to track NVMI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Nova Ltd. (NVMI) Surpasses Q4 Earnings Estimates

Nova Ltd. (NVMI) Surpasses Q4 Earnings Estimates

Nova Ltd. (NVMI) came out with quarterly earnings of $2.14 per share, beating the Zacks Consensus Estimate of $2.13 per share. This compares to earnings of $1.94 per share a year ago.

Zacks | 3 months ago
Nova Eye Medical Limited (ELXMF) Q2 2026 Earnings Call Transcript

Nova Eye Medical Limited (ELXMF) Q2 2026 Earnings Call Transcript

Nova Eye Medical Limited (ELXMF) Q2 2026 Earnings Call Transcript

Seekingalpha | 4 months ago
Nova Eye Medical Limited (ELXMF) Q2 2026 Sales/Trading Call Transcript

Nova Eye Medical Limited (ELXMF) Q2 2026 Sales/Trading Call Transcript

Nova Eye Medical Limited (ELXMF) Q2 2026 Sales/Trading Call Transcript

Seekingalpha | 4 months ago
Nova Ltd.: Agnostic AI Winner; Future Cash Cow

Nova Ltd.: Agnostic AI Winner; Future Cash Cow

Nova Limited leads in integrated, in-line materials metrology, capitalizing on rising chip complexity and AI-driven demand. NVMI targets ~$1.15B revenue by 2027, implying a 14.4% CAGR, and demonstrates exceptional free cash flow conversion averaging 99.3% since 2021. I see a clear path to ~12.65% annual returns through 2030 if purchased at a 30x P/E multiple, with a conservative price target of $458.30.

Seekingalpha | 5 months ago
Nova Eye Medical Limited (ELXMF) Discusses Clinical Insights and Practice Advantages of iTrack Advance Glaucoma Device Prepared Remarks Transcript

Nova Eye Medical Limited (ELXMF) Discusses Clinical Insights and Practice Advantages of iTrack Advance Glaucoma Device Prepared Remarks Transcript

Nova Eye Medical Limited (OTCPK:ELXMF) Discusses Clinical Insights and Practice Advantages of iTrack Advance Glaucoma Device November 25, 2025 5:30 PM EST Company Participants Mark Flynn - Investor Relations Thomas Spurling - MD & Executive Director Conference Call Participants Dr. Mahmoud Khaimi Presentation Mark Flynn Investor Relations Good morning, everyone, and thank you for joining us at Nova Eye. We're here to walk you through the clinical use of the iTrack Advance and share some direct insights from the field.

Seekingalpha | 6 months ago
Nova Ltd. (NVMI) Q3 2025 Earnings Call Transcript

Nova Ltd. (NVMI) Q3 2025 Earnings Call Transcript

Nova Ltd. ( NVMI ) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants Gabriel Waisman - President & CEO Guy Kizner - Chief Financial Officer Conference Call Participants Miri Segal-Scharia - MS-IR LLC Atif Malik - Citigroup Inc., Research Division Ezra Weener - Jefferies LLC, Research Division Vedvati Shrotre - Evercore ISI Institutional Equities, Research Division Yu Shi - Needham & Company, LLC, Research Division Presentation Operator Good morning, and welcome to Nova's Third Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded.

Seekingalpha | 6 months ago
Nova Minerals: The Alaska Gold And Antimony Bet At A Turning Point

Nova Minerals: The Alaska Gold And Antimony Bet At A Turning Point

Nova Minerals is transitioning from exploration to development, relying on capital raises with a limited cash runway and no commercial revenues yet. The Estelle Gold & Critical Minerals Project, especially the RPM and Korbel deposits, is central to NVA's future, with antimony adding strategic value. Securing a land use permit for an antimony refinery at Port MacKenzie marks a shift toward vertical integration and potential US defense sector involvement.

Seekingalpha | 7 months ago
Nova: New Product Cycles Powering Stock Higher

Nova: New Product Cycles Powering Stock Higher

Nova Ltd. has quietly outperformed in the semiconductor equipment sector over the past two years. Despite peers like KLA and Lam Research drawing more attention, NVMI has delivered superior returns. NVMI's success is driven by its ability to consistently gain market share in the industry.

Seekingalpha | 8 months ago
Nova Ltd. (NVMI) Presents At Citi's 2025 Global Technology, Media And Telecommunications Conference Transcript

Nova Ltd. (NVMI) Presents At Citi's 2025 Global Technology, Media And Telecommunications Conference Transcript

Nova Ltd. (NASDAQ:NVMI ) Citi's 2025 Global Technology, Media and Telecommunications Conference September 4, 2025 3:30 PM EDT Company Participants Gabriel Waisman - President & CEO Conference Call Participants Atif Malik - Citigroup Inc., Research Division Presentation Atif Malik Director and Semiconductor Capital Equipment & Specialty Semiconductor Analyst Good afternoon, everyone. Welcome to day 2 of Citi Global TMT Conference.

Seekingalpha | 9 months ago
Bank of Nova Scotia: Still A Buy After Strong Q3 Earnings

Bank of Nova Scotia: Still A Buy After Strong Q3 Earnings

The Bank of Nova Scotia delivered a strong Q3, beating analyst expectations with 13.5% revenue growth and 15% higher adjusted earnings year-over-year. The bank's turnaround plan is progressing, focusing on shedding weaker international assets and emphasizing growth in Canada, the U.S., and Mexico. Canadian Banking results were mixed, with higher expenses and lower net interest margins, but return on equity rebounded to 18.4%.

Seekingalpha | 9 months ago
Nova LifeStyle Stock Down as Q2 Earnings Show Narrower Loss

Nova LifeStyle Stock Down as Q2 Earnings Show Narrower Loss

NVFY's second-quarter 2025 loss narrows on improved margins, while sales dip due to continued furniture sector challenges.

Zacks | 9 months ago
Nova Shares Jump 4% on Q2 Earnings Beat, Robust Q3 Guidance

Nova Shares Jump 4% on Q2 Earnings Beat, Robust Q3 Guidance

NVMI shares rise as second-quarter earnings and revenues beat estimates, with upbeat Q3 guidance fueling investor optimism.

Zacks | 9 months ago
Loading...
Load More